Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Clinical Lung Cancer|January 3, 2025
Phase II Parallel Arm Study of Sacituzumab Govitecan-Hziy in Patients With Advanced Thymoma or Thymic CarcinomaJennifer A Marks, Jaeil Ahn, Joshua E Reuss, et al.
Clinical Lung Cancer|June 10, 2025
Chemotherapy Plus Anti-PD-1 or Anti-PD-L1 in Advanced PD-L1-Negative Squamous Cell Lung Carcinoma: A Systematic Review and Meta-AnalysisNicolas Peruzzo, Gabriel Lenz, Ted Akhiwu, et al.
JCO Oncology Practice|February 12, 2025
Inpatient Immunotherapy Outcomes Study: A Multicenter Retrospective AnalysisFauzia Riaz, John L Vaughn, Huili Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 16, 2023
Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in Resectable Non-Small Cell Lung CancerSamuel Rosner, Joshua E Reuss, Marianna Zahurak, et al.
Journal of Oncology Practice|August 7, 2019
Immune-Related Adverse Events Requiring Hospitalization: Spectrum of Toxicity, Treatment, and OutcomesAanika Balaji, Jiajia Zhang, Beatriz Wills, et al.
Frontiers in Oncology|May 11, 2023
ERBB family fusions are recurrent and actionable oncogenic targets across cancer typesLaura Schubert, Andrew Elliott, Anh T Le, et al.
Cancer Immunology, Immunotherapy : CII|February 26, 2022
Murine fecal microbiota transfer models selectively colonize human microbes and reveal transcriptional programs associated with response to neoadjuvant checkpoint inhibitorsFyza Y Shaikh, Joell J Gills, Fuad Mohammad, et al.
JTO Clinical and Research Reports|November 8, 2021
Pretreatment Lung Function and Checkpoint Inhibitor Pneumonitis in NSCLCJoshua E Reuss, Emily Brigham, Kevin J Psoter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2024
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2024
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, et al.
Pageof 6